Nagatoshi Fujiwara

Title: Nagatoshi Fujiwara: Innovator in Recombinant Human Serum Albumin

Introduction

Nagatoshi Fujiwara is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the purification of human serum albumin. With a total of 2 patents, his work has implications for pharmaceutical preparations and medical applications.

Latest Patents

Fujiwara's latest patents focus on the process for producing recombinant human serum albumin. This innovative method involves a series of purification steps, including ultrafiltration, heat treatment, acid treatment, and additional ultrafiltration. The process also utilizes cation exchangers, hydrophobic chromatography carriers, and anion exchangers, along with salting-out techniques. The result is a pure form of human serum albumin that is free from proteinous and polysaccharide contaminants, making it suitable for pharmaceutical use.

Career Highlights

Fujiwara is associated with The Green Cross Corporation, where he has been instrumental in advancing research and development in biopharmaceuticals. His expertise in gene manipulation techniques has led to the efficient purification of recombinant human serum albumin, which is crucial for various medical applications.

Collaborations

Throughout his career, Fujiwara has collaborated with notable colleagues, including Takao Ohmura and Akinori Sumi. These partnerships have fostered innovation and contributed to the success of their projects in the field of biotechnology.

Conclusion

Nagatoshi Fujiwara's contributions to the purification of recombinant human serum albumin highlight his role as a key innovator in biotechnology. His patents and work at The Green Cross Corporation continue to impact the pharmaceutical industry positively.